by Jordana Choucair | Jan 18, 2022 | Life Sciences
A small study of Israeli medical workers found that a fourth dose of the Pfizer-BioNTechCOVID-19 vaccine wasn’t enough to prevent infection with the Omicron variant. However, the extra shot did raise antibody levels. The trial’s lead researcher said the...
by Jordana Choucair | Jan 18, 2022 | M&A
Unilever PLC said it is looking to expand further into health after making a $68 billion bid for GlaxoSmithKline (GSK) PLC’s consumer health business. The acquisition would expand Unilever’s reach in oral care, vitamins, and over-the-counter medications....
by Jordana Choucair | Jan 18, 2022 | M&A
DaVita announced it has acquired transplant software company MedSleuth to ease access burdens on kidney and liver transplant candidates. DaVita said the acquisition will help the company support patients throughout their entire care journey, from kidney failure...
by Jordana Choucair | Jan 18, 2022 | Payers
A report from the Medicare Payment Advisory Commission found that the percentage of Medicare beneficiaries in Parts A and B enrolled in Medicare Advantage (MA) plans will exceed 50 percent in 2023.The panel also discovered that this year spending in MA will be 4...
by Jordana Choucair | Jan 18, 2022 | Uncategorized
Anthony Fauci said on Monday that it is too soon to say whether omicron is the final wave of the COVID-19 pandemic. Fauci said, “I would hope that that’s the case. But that would only be the case if we don’t get another variant that eludes the immune response of...
Recent Comments